Sharps Technology (NASDAQ: $STSS) is making a move few saw coming. Known as a medical-device company, Sharps is now stepping into the spotlight for something completely different: a major Solana (CRYPTO: $SOL) treasury strategy. And based on its 2025 year-end results, this is not a small side play.
By the end of 2025, the company reported holding more than 2 million SOL, with most of it staked to generate yield. That alone puts Sharps in a rare category of public companies leaning hard into crypto as part of their balance sheet strategy.
The bigger story is how dramatic the shift has been. Total assets surged from just over $7 million a year earlier to more than $269 million. The bulk of that came from digital assets, while liabilities dropped sharply and the company wiped out its prior notes payable balance.
More From Cryptoprowl:
Even more telling is where the revenue came from.
Sharps reported roughly $7 million in full-year revenue, but nearly all of it came from staking income tied to its Solana holdings. Its traditional medical-device distribution business contributed only a small fraction by comparison. That is a major signal that the company is actively reshaping its identity — and doing it fast.
For crypto investors, this is where things get interesting. We have already seen public firms use Bitcoin as a treasury asset, but Sharps is part of a newer wave pushing beyond BTC (CRYPTO: $BTC) and into Solana. That makes it one of the more intriguing ticker stories for traders watching the intersection of public markets and altcoin exposure.
The question now is not whether public companies are watching Solana — it’s who moves next.
Shares of Sharps Technology are trading at $1.52, up 0.33 percent.
